Takeda is a patient-centric, value-based biopharmaceutical company operating globally. With Research & Development as its heart and engine, its mission is to bring better health and a brighter future to people around the world. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in a successful history in Japan that spans more than 230 years.
Our research and development efforts are focused on the therapeutic areas of oncology, rare diseases, neuroscience and gastroenterology (GI). We also invest specifically in the research and development of plasma-derived therapies and vaccines.
Neuropsychiatric disorders are complex, multifaceted and impact the entire mental health spectrum. Our goal is to provide innovative medicines for people with neuropsychiatric disorders for which there are currently few or no treatment options. Our commitment extends beyond our research efforts by creating public awareness of neuroscience, educating patients and families about it, and expanding access to therapies.
